These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33315710)

  • 41. Presumptive identification of Clostridium difficile strain 027/NAP1/BI on Cepheid Xpert: interpret with caution.
    Kok J; Wang Q; Thomas LC; Gilbert GL
    J Clin Microbiol; 2011 Oct; 49(10):3719-21. PubMed ID: 21849697
    [No Abstract]   [Full Text] [Related]  

  • 42. Pembrolizumab induced steroid resistant immune mediated colitis and concurrent Clostridioides difficile infection.
    Preda CM; Marin RI; Becheanu G; Neacsu F; Manuc T; Manuc M
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):411-413. PubMed ID: 34551037
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile.
    Rogers DS; Kundrapu S; Sunkesula VC; Donskey CJ
    J Clin Microbiol; 2013 Oct; 51(10):3421-2. PubMed ID: 23926162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can Clostridium innocuum Masquerade as Clostridioides difficile?
    Skinner AM; Petrella L; Spandoni S; Serna-Perez F; Johnson S
    Clin Infect Dis; 2022 Sep; 75(7):1268-1269. PubMed ID: 35579505
    [No Abstract]   [Full Text] [Related]  

  • 45. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.
    Khanna S; Pardi D
    Am J Gastroenterol; 2020 Jul; 115(7):971-974. PubMed ID: 32618640
    [No Abstract]   [Full Text] [Related]  

  • 46. A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.
    Luk S; To WK; Ng TK; Hui WT; Lee WK; Lau F; Ching AM
    J Clin Microbiol; 2014 Feb; 52(2):671-3. PubMed ID: 24478510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SHEA neonatal intensive care unit (NICU) white paper series: Practical approaches to Clostridioides difficile prevention.
    Sandora TJ; Bryant KK; Cantey JB; Elward AM; Yokoe DS; Bartlett AH
    Infect Control Hosp Epidemiol; 2018 Oct; 39(10):1149-1153. PubMed ID: 30160646
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
    Deak E; Miller SA; Humphries RM
    J Clin Microbiol; 2014 Mar; 52(3):960-3. PubMed ID: 24352999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clostridioides difficile Infection in Children: Research Progress, Pitfalls, and Priorities.
    Kociolek LK; Burnham CD; Nicholson MR; Zackular JP
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S1-S2. PubMed ID: 34791394
    [No Abstract]   [Full Text] [Related]  

  • 50. The Laboratory Diagnosis of Clostridioides difficile Infection: An update of current laboratory practice.
    Somily AM; Khan MA; Morshed M
    J Infect Dev Ctries; 2021 Oct; 15(10):1364-1375. PubMed ID: 34780357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia.
    Alzahrani N; Johani SA
    Ann Saudi Med; 2013; 33(2):198-9. PubMed ID: 23563012
    [No Abstract]   [Full Text] [Related]  

  • 52. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
    Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
    Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
    Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expert Commentary on Clostridioides difficile Infection.
    Stewart DB
    Dis Colon Rectum; 2021 Feb; 64(2):156. PubMed ID: 33315713
    [No Abstract]   [Full Text] [Related]  

  • 55. Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
    Okanda T; Mitsutake H; Aso R; Sekizawa R; Takemura H; Matsumoto T; Nakamura S
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115247. PubMed ID: 33188946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting the tcdA gene: is this appropriate for detection of A and/or B Clostridium difficile toxin-producing strains?
    Kozak K; Elagin V; Norén T; Unemo M
    J Clin Microbiol; 2011 Jun; 49(6):2383; author reply 2383-4. PubMed ID: 21617002
    [No Abstract]   [Full Text] [Related]  

  • 57. Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks.
    Broukhanski G; Low DE; Pillai DR
    J Clin Microbiol; 2011 May; 49(5):1983-6. PubMed ID: 21411590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of an electronic hard-stop clinical decision support tool to limit repeat
    Kwon JH; Reske KA; Hink T; Jackups R; Burnham CD; Dubberke ER
    Infect Control Hosp Epidemiol; 2019 Dec; 40(12):1423-1426. PubMed ID: 31647044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
    Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
    J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical management of severe, fulminant, and refractory
    Cheng YW; Fischer M
    Expert Rev Anti Infect Ther; 2020 Apr; 18(4):323-333. PubMed ID: 32057278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.